Charles Drew entered medicine at a time when Black physicians were expected to be excellent and still denied full access to hospitals, residencies, professional networks, and research posts. He was born in Washington, D.C., in 1904, grew up in a middle-class Black community, and first became widely known as an athlete. At Amherst College he played football and ran track, but his deeper ambition moved toward medicine. He trained at McGill University in Canada, where his surgical skill and academic record stood out.

The medical problem that made Drew famous was urgent and practical. Blood transfusion could save lives, but whole blood spoiled quickly and was difficult to store and move. Plasma, the liquid part of blood, could be separated, preserved longer, dried, and transported more easily. Drew did not work alone, and he did not magically invent the entire blood bank by himself. What he did was refine, standardize, and organize the process at a scale that made it dependable.

At Columbia University, Drew wrote doctoral research on banked blood and became one of the leading experts on plasma preservation. That expertise became crucial as World War II intensified. Britain needed blood and plasma for wounded soldiers and civilians. Drew directed Blood for Britain, a program that collected blood in the United States, processed it, and shipped plasma overseas. It required scientific precision, but also logistics: sterile collection, testing, refrigeration, packaging, transport, records, and training. Drew understood that lifesaving medicine depended on the system around the discovery.

That systems knowledge is why Drew belongs in an encyclopedia page rather than only a list of inventors. Blood collection had to be trusted by donors, reliable for doctors, and safe for patients. Drew helped create standards for separating plasma, labeling units, preventing contamination, and moving supplies before they expired. In wartime, a mistake was not a typo. It could mean a wounded person died before surgery.

In 1941, the American Red Cross asked Drew to help organize its first large-scale blood bank program. The contradiction arrived almost immediately. The U.S. military first refused blood donations from Black people, then accepted them only if the blood was segregated by race. The policy had no scientific basis. Drew criticized it and later stepped away from the Red Cross program. The same country that needed his expertise refused to let science fully overrule racism.

Drew spent much of the rest of his career at Howard University and Freedmen's Hospital, where he trained Black surgeons and raised standards for medical education. That part of his life matters because it shows his work was not only wartime technology. It was institution building. He pushed for Black doctors to receive the training and recognition that segregated medicine tried to deny them.

His death in 1950 created one of the most persistent myths in Black medical history. Drew died after a car crash in North Carolina. A widely repeated story says he was denied treatment or blood because he was Black. The National Library of Medicine notes that this was repeatedly shown to be false. The myth lasted because it sounded believable in a country where Black patients were often mistreated and Black doctors excluded. The truth is more complicated: Drew was treated after the crash, but his injuries were too severe. Correcting the myth does not soften medical racism. It keeps Drew's actual life from being swallowed by a false ending.

Drew's story is strongest when held in full. He was a scientist, surgeon, organizer, teacher, and critic of racist policy. He helped make blood banking modern, then used his career to train the next generation of Black physicians. The lesson is not simply that he saved lives. It is that medicine needs both discovery and justice to be worthy of the people it claims to serve.